[go: up one dir, main page]

GB0806978D0 - Novel formulations - Google Patents

Novel formulations

Info

Publication number
GB0806978D0
GB0806978D0 GBGB0806978.3A GB0806978A GB0806978D0 GB 0806978 D0 GB0806978 D0 GB 0806978D0 GB 0806978 A GB0806978 A GB 0806978A GB 0806978 D0 GB0806978 D0 GB 0806978D0
Authority
GB
United Kingdom
Prior art keywords
novel formulations
formulations
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0806978.3A
Other versions
GB2461681A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmasol Ltd
Original Assignee
Pharmasol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasol Ltd filed Critical Pharmasol Ltd
Priority to GB0806978A priority Critical patent/GB2461681A/en
Publication of GB0806978D0 publication Critical patent/GB0806978D0/en
Priority to US12/386,507 priority patent/US20090270438A1/en
Priority to PCT/GB2009/050383 priority patent/WO2009127878A1/en
Publication of GB2461681A publication Critical patent/GB2461681A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0806978A 2006-10-18 2008-04-17 Buprenorphine liquid spray formulation with solvent and antioxidant Withdrawn GB2461681A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0806978A GB2461681A (en) 2008-04-17 2008-04-17 Buprenorphine liquid spray formulation with solvent and antioxidant
US12/386,507 US20090270438A1 (en) 2006-10-18 2009-04-17 Novel compositions and formulations
PCT/GB2009/050383 WO2009127878A1 (en) 2008-04-17 2009-04-17 A liquid spray solution comprising buprenorphine, ethanol and an antioxidant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0806978A GB2461681A (en) 2008-04-17 2008-04-17 Buprenorphine liquid spray formulation with solvent and antioxidant

Publications (2)

Publication Number Publication Date
GB0806978D0 true GB0806978D0 (en) 2008-05-21
GB2461681A GB2461681A (en) 2010-01-13

Family

ID=39472246

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0806978A Withdrawn GB2461681A (en) 2006-10-18 2008-04-17 Buprenorphine liquid spray formulation with solvent and antioxidant

Country Status (2)

Country Link
GB (1) GB2461681A (en)
WO (1) WO2009127878A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
DK3043777T3 (en) 2013-09-10 2020-07-20 Fresh Cut Dev Llc SUBLINGUAL BUPRENORPHINSPRAY
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
GB201404139D0 (en) * 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
EP3368013B1 (en) * 2015-10-27 2023-11-08 Benuvia Therapeutics, LLC Liquid buprenorphine formulations
US10085971B2 (en) 2016-08-22 2018-10-02 Navinta Iii Inc Pharmaceutical solution of asenapine for sublingual or buccal use
CA3077627A1 (en) * 2017-10-20 2019-04-25 Chiesi Farmaceutici S.P.A. Pharmaceutical formulations comprising opioid receptor agonist as active ingredients, methods of manufacture and therapeutic uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8533582A (en) * 1981-07-10 1984-01-12 Reckitt & Colman Products Limited Stable solutions of buprenorphine
EP1296649A2 (en) * 2000-06-22 2003-04-02 Pharmasol Limited Pharmaceutical compositions comprising an opioid analgesic
GB2392093B (en) * 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
JP2006516963A (en) * 2003-02-04 2006-07-13 クリサリス テクノロジーズ インコーポレイテッド Aerosol formulation and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem
EP1750675B1 (en) * 2004-06-02 2008-10-29 Galephar M/F Stable oral pharmaceutical compositions of buprenorphine and salt thereof
WO2006099651A1 (en) * 2005-03-24 2006-09-28 Unipack Ges.M.B.H. Liquid aqueous dosage forms for sub-lingual or nasal applications of active agents with amino groups
AR058193A1 (en) * 2005-11-21 2008-01-23 Schering Plough Ltd PHARMACEUTICAL COMPOSITIONS
GB0620661D0 (en) * 2006-10-18 2006-11-29 Pharmasol Ltd Novel compounds

Also Published As

Publication number Publication date
WO2009127878A1 (en) 2009-10-22
GB2461681A (en) 2010-01-13

Similar Documents

Publication Publication Date Title
GB0815435D0 (en) Formulations
GB2459691B (en) Formulations
ZA201106050B (en) Dye-polymers formulations
GB0711656D0 (en) Formulations
GB0716385D0 (en) Formulations
GB0823269D0 (en) Formulations
ZA200908969B (en) Formulations
GB0720716D0 (en) Novel formulation
IL269369A (en) Improved formulations
GB0821789D0 (en) Formulations
GB0809979D0 (en) Formulations
GB0919210D0 (en) Formulations
GB0711957D0 (en) Formulations
EP2307021A4 (en) Formulations
GB0806978D0 (en) Novel formulations
ZA201004772B (en) Novel formulation
GB0810232D0 (en) Formulations
GB0705179D0 (en) Formulations
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
IL217390A0 (en) Formulations
GB0813121D0 (en) Novel formulations
GB0811447D0 (en) Formulations
GB0816876D0 (en) Formulations

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)